Skip to content

Form 4 filed by NEWHALL CHARLES W III

NEWHALL CHARLES W III filed this Form 4 on SUPN (SUPERNUS PHARMACEUTICALS, INC.) with 13 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 21:26:21 UTC.

Accession
0001005544-26-000006
Filed
2026-11-04
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Issuer and reporting owners

Issuer: SUPN · SUPERNUS PHARMACEUTICALS, INC. (CIK 1356576)

Rows

SecurityDateCodeSharesPriceOwned afterOwnership
Common Stock 2026-11-02J other-124,119$00D
Restricted Stock Unit derivative2026-11-02J other-2,989$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-7,905$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-6,036$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-8,613$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-12,427$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-9,305$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-7,365$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-6,847$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-6,293$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-8,252$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-7,296$00D
Director Stock Option (Right to Buy) derivative2026-11-02J other-4,977$00D